Tsg101 chaperone function revealed by HIV-1 assembly inhibitors
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
HIV-1 replication requires Tsg101, a component of cellular endosomal sorting complex required for transport (ESCRT) machinery. Tsg101 possesses an ubiquitin (Ub) E2 variant (UEV) domain with a pocket that can bind PT/SAP motifs and another pocket that can bind Ub. The PTAP motif in the viral structural precursor polyprotein, Gag, allows the recruitment of Tsg101 and other ESCRTs to virus assembly sites where they mediate budding. It is not known how or even whether the UEV Ub binding function contributes to virus production. Here, we report that disruption of UEV Ub binding by commonly used drugs arrests assembly at an early step distinct from the late stage involving PTAP binding disruption. NMR reveals that the drugs form a covalent adduct near the Ub-binding pocket leading to the disruption of Ub, but not PTAP binding. We conclude that the Ub-binding pocket has a chaperone function involved in bud initiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding
Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. H., Wang, H. E., Wettstein, D. A., Stray, K. M., Côté, M., Rich, R. L., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00506-2 · Cited by 1,369 · cited 1×
“As inhibitors of HIV-1 assembly, the drugs’ action appears to be specifically targeted: (1) Inhibitory effects on Gag assembly were observed at concentrations well below drug toxicity as assessed using tests based on cell metabolic activity (Supplementary Fig.”
BackgroundParallels Between Cytokinesis and Retroviral Budding: A Role for the ESCRT Machinery
Carlton, J. G., & Martin-Serrano, J. (2007) · Science · doi:10.1126/science.1143422 · Cited by 764
Martin-Serrano, J., Zang, T., & Bieniasz, P. D. (2001) · Nature Medicine · doi:10.1038/nm1201-1313 · Cited by 710 · cited 1×
“(2) Inhibition of virus production by the drug was neutralized by N-Acetyl Cysteine (Supplementary Fig.”
BackgroundTsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55 Gag
VerPlank, L., Bouamr, F., LaGrassa, T. J., Agresta, B., Kikonyogo, A., Leis, J., & Carter, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131059198 · Cited by 584 · cited 1×
“(3) Inhibition of virus production was suppressed by replacing endogenous Tsg101 with Tsg101 C73A, a Tsg101 mutant lacking the residue with which the drug forms a covalent adduct.”
BackgroundSelf-citationA role for ubiquitin ligase recruitment in retrovirus release
Strack, B., Calistri, A., Accola, M. A., Palù, G., & Göttlinger, H. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13063 · Cited by 309
Ubiquitin is part of the retrovirus budding machinery
Patnaik, A., Chau, V., & Wills, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13069 · Cited by 292
Carlson, L.-A., Briggs, J. A. G., Glass, B., Riches, J. D., Simon, M. N., Johnson, M. C., Müller, B., Grünewald, K., & Kräusslich, H.-G. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.10.013 · Cited by 230
Demirov, D. G., Orenstein, J. M., & Freed, E. O. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.105-117.2002 · Cited by 201
Tavassoli, A., Lu, Q., Gam, J., Pan, H., Benkovic, S. J., & Cohen, S. N. (2008) · ACS Chemical Biology · doi:10.1021/cb800193n · Cited by 153
Dussupt, V., Javid, M. P., Abou-Jaoudé, G., Jadwin, J. A., de La Cruz, J., Nagashima, K., & Bouamr, F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000339 · Cited by 148
Cited by
Importance of viral late domains in budding and release of enveloped RNA viruses
Welker, L., Paillart, J.-C., & Bernacchi, S. (2021) · Viruses · doi:10.3390/v13081559 · Cited by 36
Budding of a Retrovirus: Some Assemblies Required
Rose, K. M., Hirsch, V. M., & Bouamr, F. (2020) · Viruses · doi:10.3390/v12101188 · Cited by 32
“already been developed that are aimed at disrupting this critical interface [53], they interfere with”
BackgroundRecent advances in HIV-1 Gag inhibitor design and development
Dick, A., & Cocklin, S. (2020) · Molecules · doi:10.3390/molecules25071687 · Cited by 28
Hoffman, H. K., Fernandez, M. V., Groves, N. S., Freed, E. O., & van Engelenburg, S. B. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009372 · Cited by 28
“We gave special attention to characterizing the interaction of Tsg101 with HIV-1 Gag in our system, because the essential role of Tsg101-Gag binding in HIV-1 replication makes it a potential target for new classes of antiretroviral therapy (27, 28).”
Metadata
- Authors
- Strickland, M., Ehrlich, L. S., Watanabe, S., Khan, M., Strub, M.-P., Luan, C.-H., Powell, M. D., Leis, J., Tjandra, N., & Carter, C. A.
- Venue
- Nature Communications
- Published
- 2017-11-09
- Volume
- 8
- Issue
- 1
- Pages
- 1391-1391
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2765273889
- Cited by
- 55
- References
- 12
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tsg101 chaperone function revealed by HIV-1 assembly inhibitors. https://app.cochat.ai/papers/10.1038/s41467-017-01426-2
- The paper
- Strickland, M., Ehrlich, L. S., Watanabe, S., Khan, M., Strub, M.-P., Luan, C.-H., Powell, M. D., Leis, J., Tjandra, N., & Carter, C. A. (2017). Tsg101 chaperone function revealed by HIV-1 assembly inhibitors. Nature Communications. https://doi.org/10.1038/s41467-017-01426-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.